Open AccessThe benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia
Author(s) -
João Gonçalves-Pereira,
L. Costa,
Izabella Barreto Romualdo Silva,
André Simões,
Filipe Froes,
Paulo Mergulhão,
Patrícia Varela Ramos,
Danilo Marques Leal,
Rhayssa Marques Rodrigues Alves,
M. Custódio,
André Gomes
Publication year - 2022
Publication title -
pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.826
H-Index - 22
eISSN - 2531-0437
pISSN - 2531-0429
DOI - 10.1016/j.pulmoe.2022.08.003
Subject(s) - medicine , bacteremia , pneumonia , intensive care medicine , pneumococcal pneumonia , streptococcus pneumoniae , antibiotics , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom